From Questionnaires to Conversations: Improving Clinical Trial Feasibility

Almenia Garvey brings over 25 years of expertise in Site and Investigator Relations, with a proven track record of driving global strategies that enhance clinical trial execution. She has also led and contributed to initiatives advancing diversity and inclusion in clinical trials, with a focus on improving access, representation and patient-centric approaches across global study populations. In her current role as Executive Director, Global Feasibility, Site and Patient Engagement at Allucent, Almenia leads the organization’s global site and patient engagement strategy, building robust site intelligence to optimize site identification and accelerate study start-up and delivery.

Almenia holds a Master of Science degree from Ulster University, N. Ireland and a Bachelor’s degree from the University of North Carolina at Chapel Hill. In addition, Almenia is an EMCC-accredited Coach Practitioner and actively contributes to the community by serving on the Board of Directors for two charities: Nvolve and Brandon’s Baggies.

Christine Khoza has more than 23 years’ professional experience in clinical research. As Executive Director and Global Head of Study Start-Up & Site Intelligence at Allucent, she ensures planning, preparation and execution of study start-up activities, from site identification to site activation. With a strong foundation in data-driven decision-making, Christine combines scientific rigor, strategic leadership, and operational expertise to enhance clinical trial efficiency and outcomes. Her career reflects a consistent track record of leading high-performing teams, streamlining global processes, and delivering scalable solutions in highly regulated environments.